#novartis — Public Fediverse posts

Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton » Dallas Innovates

Novartis breaks ground on its Denton radioligand therapy site. [Photo: Novartis] Swiss gl…
#Switzerland #CH #Europe #Europa #EU #DepartmentofCommerceUnderSecretaryforIndustryandSecurityJeffreyKessler #Nachrichten #Nouvelles #Novartis #pharmaceuticalmanufacturing #radioligandtherapy #RLT #schweiz #Suisse #switzerland #TexasStateSenatorBrentHagenbuch #VasNarasimhan
https://www.europesays.com/2985151/

Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton » Dallas Innovates https://www.byteseu.com/2014617/ #DepartmentOfCommerceUnderSecretaryForIndustryAndSecurityJeffreyKessler #Novartis #PharmaceuticalManufacturing #RadioligandTherapy #RLT #Switzerland #TexasStateSenatorBrentHagenbuch #VasNarasimhan

https://www.europesays.com/ch/64386/ Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton » Dallas Innovates #DepartmentOfCommerceUnderSecretaryForIndustryAndSecurityJeffreyKessler #Novartis #PharmaceuticalManufacturing #RadioligandTherapy #RLT #Switzerland #TexasStateSenatorBrentHagenbuch #VasNarasimhan

https://www.europesays.com/ch/64350/ Novartis Finalizes U.S. Manufacturing, R&D Expansion Plan #APIManufacturing #CapitalInvestment #CorporateExpansion #Denton #EconomicDevelopment #expansion #Manufacturing #NorthCarolina #Novartis #R&D #RadioligandTherapy #RLTManufacturing #Texas #WakeCounty

https://www.europesays.com/ch-fr/128185/ Les médicaments stars tombés dans le domaine public feront-ils de l’ombre aux grandes pharmas? #brevet #Business #Économie #ÉconomieEtFinances #Economy #IndustrieChimique #IndustrieDesSoinsDeSanté #IndustriePharmaceutique #Médicament #MédicamentGénérique #Microéconomie #Novartis #pharmacie #RocheHolding #Santé #ScienceEtTechnologie #Suisse

https://www.europesays.com/ch/63807/ Novartis Bets on India R&D Hub Post-Divestment #Ahmedabad #CardiovascularDisease #ClinicalTrials #DrugDevelopment #GlobalHub #Immunology #India #Novartis #Oncology #PharmaceuticalInnovation #R&D

https://www.europesays.com/ch/63227/ Working with communities to close gaps in heart disease and cancer care #cancer #communities #CommunityHealthLaunch #HiddenHeartDisease #InclusiveHealthAccelerators #Novartis

https://www.europesays.com/ch/63011/ Is It Too Late To Consider Novartis (SWX:NOVN) After Its Strong 1-Year Share Price Run? #DCF #FairValue #FreeCashFlow #Novartis #SharePrice

https://www.europesays.com/ch/62758/ Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility #CancerPatients #CancerTreatments #Manufacturing #ManufacturingFacility #NorthCarolina #Novartis #ResearchAndDevelopment #RLT

https://www.europesays.com/ch/62146/ Construction begins on Novartis’ RLT centre in Texas, US #Denton #Manufacturing #ManufacturingFacility #Novartis #RadioligandTherapy #RLT #Texas

https://www.europesays.com/ch/62125/ Novartis breaks ground on $280M facility in Denton for next-gen cancer treatment – NBC 5 Dallas-Fort Worth #Denton #Novartis

https://www.europesays.com/ch/61663/ Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities #CancerTreatments #Denton #Manufacturing #MedicinesCompany #Novartis #RadioligandTherapy #RLT #Texas #TexasStateSenator

5 Things to Know: Running Back Kaelon Black https://www.rawchili.com/nfl/884788/ #2026Draft #2026DraftNews #49ers #5ThingsToKnow #BrookeEvans #English #EnglishArticles #Football #FreeAgency2026 #KaelonBlack #KyleShanahan #LatestApp #news #NewsDraft #NFL #novartis #SanFrancisco #SanFrancisco49ers #SanFrancisco #SanFrancisco49ers

5 Things to Know: Running Back Kaelon Black https://www.rawchili.com/nfl/884788/ #2026Draft #2026DraftNews #49ers #5ThingsToKnow #BrookeEvans #English #EnglishArticles #Football #FreeAgency2026 #KaelonBlack #KyleShanahan #LatestApp #news #NewsDraft #NFL #novartis #SanFrancisco #SanFrancisco49ers #SanFrancisco #SanFrancisco49ers

https://www.europesays.com/ch/61085/ Pharma company Novartis plans $220-million RTP investment #APPLocalBusiness #AppTopStoriesNC #business #CentralNC #Charlotte #coastal #DanielGray #mountain #news #NorthCarolina #Novartis #Triad

https://www.europesays.com/ch/59829/ Novartis partners with Special Olympics World Winter Games Switzerland 2029 #AthletesWithIntellectualDisabilities #belonging #CommunityEngagement #CorporatePartnership #disability #equality #GlobalSportsEvent #InclusiveGlobalEvent #InclusiveSportsCompetition #InternationalWinterSports #neuroinclusion #neurodiversity #Novartis #SocialImpact #SOWWG #SpecialOlympics #SpecialOlympicsWorldWinterGames #Sports #Switzerland2029 #WorldWinterGames2029

5 Things to Know: Wide Receiver De’Zhaun Stribling https://www.rawchili.com/nfl/879852/ #2026Draft #2026DraftNews #49ers #5ThingsToKnow #BrookeEvans #De'ZhaunStribling #English #EnglishArticles #Football #FreeAgency2026 #LatestApp #news #NewsDraft #NFL #novartis #SanFrancisco #SanFrancisco49ers #SanFrancisco #SanFrancisco49ers

5 Things to Know: Wide Receiver De’Zhaun Stribling https://www.rawchili.com/nfl/879852/ #2026Draft #2026DraftNews #49ers #5ThingsToKnow #BrookeEvans #De'ZhaunStribling #English #EnglishArticles #Football #FreeAgency2026 #LatestApp #news #NewsDraft #NFL #novartis #SanFrancisco #SanFrancisco49ers #SanFrancisco #SanFrancisco49ers

https://www.europesays.com/ch/58214/ Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility #CancerPatients #CancerTreatments #Manufacturing #ManufacturingFacility #NorthCarolina #Novartis #ResearchAndDevelopment #RLT

https://www.europesays.com/ch/57615/ Novartis’ Q1 sales miss hints at industry’s utilisation of M&A remedies #decline #GlobalData #MukulMehta #Novartis #PharmaIndustry #Q2Sales #SalesPlummeting

https://www.europesays.com/ch/57370/ Novartis Q1 Earnings Call Highlights #ChiefFinancialOfficerMukulMehta #Narasimhan #Novartis #OperatingIncome #PercentagePoints #SalesGrowth #US #VasNarasimhan

https://www.europesays.com/ch/57200/ Novartis Q1 Earnings & Revenues Miss Estimates, Stock Down – April 28, 2026 #financial #FinancialPlanning #Investing #investment #InvestmentAdvice #Novartis #OnlineInvestment #OnlineStockTrading #OnlineTrading #quote #quotes #stock #StockMarket #StockQuotes #stocks

https://www.europesays.com/ch/57171/ Novartis Q1 Earnings & Revenues Miss Estimates, Stock Down – April 28, 2026 #financial #FinancialPlanning #Investing #investment #InvestmentAdvice #Novartis #OnlineInvestment #OnlineStockTrading #OnlineTrading #quote #quotes #stock #StockMarket #StockQuotes #stocks

https://www.europesays.com/ch/57148/ Novartis misses quarterly sales, profit estimates as Entresto generics hit growth #as #Entresto #estimates #generics #growth #hit #misses #Novartis #profit #quarterly #Sales

https://www.europesays.com/ch/56953/ Novartis misses quarterly sales, profit estimates as Entresto generics hit growth #AnalystExpectations #Entresto #MarketExpectations #NetSales #Novartis #OperatingProfit #SalesGrowth #VisibleAlpha

https://www.europesays.com/ch/56852/ Novartis Faces Sales and Profit Decline Amid Entresto Generic Competition, ETPharma #CoreOperatingProfit #Entresto #GenericCompetition #Novartis #QuarterlySales

https://www.europesays.com/ch/56822/ Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months #AstraZenecaPLC #BreakingNews:Politics #business #BusinessNews #DonaldTrump #GileadSciencesInc #HealthCareIndustry #Novartis #NovartisAG #Pharmaceuticals #politics #RocheHoldingAG #SanofiSA #UnitedStates

https://www.europesays.com/ch/56759/ Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed #2026 #and #Brands #delivered #FY #growth #guidance #in #launches #Novartis #priority #Q1; #reaffirmed #Strong

Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria

Significant improvements as early as Week 1, favorable safety profile and no liver safety concerns in REMIX 1 & 2 studies of highly…
#Europe #EU #EuropeanCommission #asfirstoral #chronic #Commissionapproval #for #Novartis #receivesEuropean #Rhapsido® #spontaneous #targeted #treatment #urticaria
https://www.europesays.com/europe/23672/

https://www.europesays.com/ch/56243/ Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria  #as first oral #chronic #Commission approval #for #Novartis #receives European #Rhapsido® #spontaneous #targeted #treatment #urticaria

https://www.europesays.com/ch/55369/ Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants #Baby #Coartem® #Novartis #prequalification #treatment #UncomplicatedMalaria #WorldHealthOrganization

https://www.europesays.com/ch/55083/ Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings #ArrowheadPharmaceuticals #BTK #EuropeanMedicinesAgency #Novartis #PharmaceuticalTechnology #Sanofi

https://www.europesays.com/ch/55054/ Germany Anemia Treatment Market Forecast and Company Analysis Report 2026-2034 Featuring Akebia Therapeutics, GSK, Vertex, Pfizer, Sanofi, Takeda, Novartis, Johnson & Johnson, Roche, Biocon Biologics #Anemia #ChronicDiseases #Germany #IntravenousIron #IronDeficiency #IronDeficiencyAnemia #MarketAnalysis #MarketSize #Novartis

https://www.europesays.com/ch/54951/ Novartis receives positive CHMP opinion for Itvisma® for #CellAndGeneTherapy #MediaRelease #Neuroscience #Novartis #NovartisPharmaAG #RareDiseases #ReimagineMedicine #SwissStockExchange:NOVNSW

https://www.europesays.com/ch/54806/ Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants #Baby #Coartem® #Novartis #prequalification #treatment #UncomplicatedMalaria #WorldHealthOrganization

https://www.europesays.com/ch/54785/ Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants #Baby #Coartem® #Novartis #prequalification #treatment #UncomplicatedMalaria #WorldHealthOrganization

https://www.europesays.com/ch/54776/ Is It Too Late To Consider Novartis (SWX:NOVN) After Its 30% One-Year Rally? #DCF #EarningsGrowth #FairValue #FreeCashFlow #IntrinsicValue #Novartis #SharePrice

https://www.europesays.com/ch/54766/ Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants #access #and #Baby #Coartem® #for #greater #infants #Malaria #newborns #Novartis #paving #prequalification #receives #treatment #way #WHO #Young

https://www.europesays.com/ch/54526/ Unveiling Novartis (NVS) Q1 Outlook: Wall Street Estimates for Key Metrics #Novartis #revenues #WallStreetAnalysts

https://www.europesays.com/ch/51746/ NIPER Mohali and Novartis Partner to Accelerate Pharma Innovation and Academic Research #DepartmentOfPharmaceuticals #DrugDevelopment #HealthcareInnovation #IndiaPharmaSector #IndustryAcademiaCollaboration #NIPERMohali #Novartis #NovartisIndia #PharmaceuticalResearch #R&DInnovation #ScientificResearch

https://www.europesays.com/ch/51654/ Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Moves And Long Term Returns #CHF #FairValue #IndividualInvestors #IntrinsicValue #Novartis #NovartisStock #SharePrice

https://www.europesays.com/ch/50806/ Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation #AllergicDisease #allergy #AntiIgE #Excellergy #Exl111 #FoodAllergy #Inc #Novartis #PharmacokineticData #ProposedAcquisition

https://www.europesays.com/ch/50207/ Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs #ChiefScientificOfficer #EmergingTechnologies #Instem #Novartis #preclinical #PreclinicalScience #RegulatoryInfrastructure #RegulatorySubmission #Szczepan #SzczepanBaran #translational

https://www.europesays.com/ch/49847/ Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030 #cancer #CancerCare #CareCommunities #ChronicDiseases #HealthSystems #HeartAttack #HeartDisease #MiddleIncomeCountries #Novartis #NovartisFoundation #PopulationHealth #ProstateCancer

https://www.europesays.com/ch/49677/ Anthropic Adds Novartis CEO Vas Narasimhan To Board #AbortionRights #Bidenomics #BorderSecurity #CaliforniaIndianNews #DepartmentOfGovernmentEfficiency #DobbsDecision #DOGE #DonaldTrump #ElectionIntegrity #ElonMusk #HeritageFoundation #IndianAmericanNews #IndianAmericanUpdates #IndianOrigin #lawfare #Novartis #Project2025 #RituJha #SouthAsianCommunityNews #SouthAsianDiaspora #SouthAsianNews #SwingStates #USIndianNews #VivekRamaswamy

https://www.europesays.com/ch/46574/ Novartis Loses Appeal to Halt Mississippi Drug Discount Law #DrugPricing #Hospitals #Novartis #PharmacyCare #preemption #UninsuredPatients

https://www.europesays.com/ch/46513/ Novartis expands community health programs to close gaps in heart disease and cancer care, targeting 30+ countries by 2030 #cancer #ChronicDisease #HeartDisease #Novartis #PublicHealth

https://www.europesays.com/ch/?p=43197 Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3% #DiseaseProgression #IgANephropathy #KidneyDamage #KidneyFailure #KidneyFunction #Novartis

Drugmakers are delaying launches of some new medicines in Europe as the industry grapples with U.S. pressure and pricing policy shifts from U.S. President Donald Trump. https://www.japantimes.co.jp/business/2026/04/01/markets/drugmakers-europe-trump-policies/?utm_medium=Social&utm_source=mastodon #business #markets #pharmaceuticals #drugmakersiran #middleeast #shipping #cancer #europe #eu #roche #novartis #astrazeneca

https://www.europesays.com/ch/41440/ Something of a shopping spree: Novartis to acquire US-based Excellergy for up to $2bn #Acquisition #allergy #antibody #asthma #IgE #Novartis #Switzerland